Home NDC 42799-709 Yargesa
Product NDC 42799-709
11-digit product format 427990709
Labeler code 42799
Product ID 42799-709_462f6c9d-b8f1-3a76-e063-6294a90a2b50
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Miglustat
Dosage form CAPSULE
Route ORAL
Labeler Edenbridge Pharmaceuticals LLC.
Application ANDA209821
Marketing category ANDA
Marketing start 2020-08-06
Substance MIGLUSTAT
Active strength 100 mg/1
Pharmacologic classes Enzyme Stabilizer [EPC], Enzyme Stabilizers [MoA], Glucosylceramide Synthase Inhibitor [EPC], Glucosylceramide Synthase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A209821-001 YARGESA MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A209821-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 c0c555d07b60…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A209821-001 MIGLUSTAT 100MG CAPSULE / ORAL AB 2020-08-06 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A209821-001 YARGESA 100MG CAPSULE / ORAL AB 2020-08-06 a50c72e98297…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base Yargesa
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength MIGLUSTAT 100 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination ADN3S497AZ Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 401938 Internal RxNorm lookup 2642350 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 42799-709-01 Yargesa 6 in 1 CARTON CAPSULE 6 5 42799-709-01 Yargesa 15 in 1 BLISTER PACK CAPSULE 15 5 42799-709-15 Yargesa 1 in 1 CARTON CAPSULE 1 5 42799-709-15 Yargesa 15 in 1 BLISTER PACK CAPSULE 15 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 42799-709 YARGESA (MIGLUSTAT) CAPSULE [EDENBRIDGE PHARMACEUTICALS LLC.] 3 Current NDC, 4 package rows 20250418_2b371dfe-e2b0-47fe-b677-a7bde7149f87.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 42799-709-01 42799070901 6 in 1 CARTON Historical 42799-709-15 42799070915 1 BLISTER PACK in 1 CARTON (42799-709-15) / 15 CAPSULE in 1 BLISTER PACK 1 blister pack 2023-10-31 No No Current